ECSP003353A - Inhibidores de proteasas ix - Google Patents
Inhibidores de proteasas ixInfo
- Publication number
- ECSP003353A ECSP003353A ECSP003353A ECSP003353A EC SP003353 A ECSP003353 A EC SP003353A EC SP003353 A ECSP003353 A EC SP003353A EC SP003353 A ECSP003353 A EC SP003353A
- Authority
- EC
- Ecuador
- Prior art keywords
- excessive
- compounds
- disease
- matrix degradation
- present
- Prior art date
Links
- 229940042399 direct acting antivirals protease inhibitors Drugs 0.000 title 1
- 239000000137 peptide hydrolase inhibitor Substances 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 3
- 206010065687 Bone loss Diseases 0.000 abstract 2
- 108091005804 Peptidases Proteins 0.000 abstract 2
- 239000004365 Protease Substances 0.000 abstract 2
- 230000015556 catabolic process Effects 0.000 abstract 2
- 238000006731 degradation reaction Methods 0.000 abstract 2
- 239000011159 matrix material Substances 0.000 abstract 2
- 208000030136 Marchiafava-Bignami Disease Diseases 0.000 abstract 1
- 208000029725 Metabolic bone disease Diseases 0.000 abstract 1
- 208000010191 Osteitis Deformans Diseases 0.000 abstract 1
- 208000001132 Osteoporosis Diseases 0.000 abstract 1
- 208000027868 Paget disease Diseases 0.000 abstract 1
- 102000035195 Peptidases Human genes 0.000 abstract 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 abstract 1
- 206010003246 arthritis Diseases 0.000 abstract 1
- -1 captesin K Substances 0.000 abstract 1
- 210000000845 cartilage Anatomy 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 125000001033 ether group Chemical group 0.000 abstract 1
- 208000024693 gingival disease Diseases 0.000 abstract 1
- 208000007565 gingivitis Diseases 0.000 abstract 1
- 150000004677 hydrates Chemical class 0.000 abstract 1
- 230000000148 hypercalcaemia Effects 0.000 abstract 1
- 208000030915 hypercalcemia disease Diseases 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 239000000543 intermediate Substances 0.000 abstract 1
- 230000003211 malignant effect Effects 0.000 abstract 1
- 208000027202 mammary Paget disease Diseases 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 201000008482 osteoarthritis Diseases 0.000 abstract 1
- 201000001245 periodontitis Diseases 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 206010039073 rheumatoid arthritis Diseases 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
El presente invento proporciona inhibidores de proteasas con estructura de éteres anulares de 7 14 miembros y sales, hidratos y solvatos farmacéuticamente aceptables de los mismos, que inhiben proteasa, incluyendo la captesina K composiciones framacéuticas de dichos compuestos: nuevos productos intermedios de dichos compuestos y métodos para tratar enfermedades por una excesiva pérdida ósea o una excesiva degradación carrilaginosa o matricial, incluyendo osteoporosis, enfermedades gingivales que incluyen gingivitis y periodontitis, artritis, más especificamente osteoartritis y artritis reumatoide, enfermedad de Paget, hipercalcemia maligna y enfermedad ósea metabólica, que comprenden inhibir dicha pérdida ósea o dicha excesiva degradación cartilaginosa o matricial mediante la administración de un compuesto del presente invencto a un paciente que lo necesita.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ECSP003353 ECSP003353A (es) | 2000-02-17 | 2000-02-17 | Inhibidores de proteasas ix |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ECSP003353 ECSP003353A (es) | 2000-02-17 | 2000-02-17 | Inhibidores de proteasas ix |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP003353A true ECSP003353A (es) | 2000-06-19 |
Family
ID=42040984
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ECSP003353 ECSP003353A (es) | 2000-02-17 | 2000-02-17 | Inhibidores de proteasas ix |
Country Status (1)
| Country | Link |
|---|---|
| EC (1) | ECSP003353A (es) |
-
2000
- 2000-02-17 EC ECSP003353 patent/ECSP003353A/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UY26625A1 (es) | Inhibidores de proteasas | |
| NO20013124L (no) | Protease inhibitorer | |
| AP9801222A0 (en) | Proatease inhibitors. | |
| UY27700A1 (es) | Compuestos oxo - azabiclícos. | |
| PA8589701A1 (es) | Ureas substituidas y carbamatos utiles para el tratamiento de la enfermedad de alzheimer | |
| BR9809333A (pt) | Inibidores de proteases | |
| MXPA02012442A (es) | Inhibidores de proteasa. | |
| WO1999059526A3 (en) | Protease inhibitors | |
| UY26026A1 (es) | Inhibidores de proteasas | |
| HK1042695A1 (zh) | 蛋白酶抑制剂 | |
| UY26088A1 (es) | Inhibidores de proteasas | |
| HK1041690A1 (zh) | 蛋白酶抑制剂 | |
| ECSP003353A (es) | Inhibidores de proteasas ix | |
| UY27032A1 (es) | Inhibidores de proteasas | |
| WO2002092563A3 (en) | Protease inhibitors | |
| UY26771A1 (es) | Inhibidores de proteasas | |
| ECSP992959A (es) | Inhibidores de proteasa de bis- aminometil carbonilo | |
| ECSP003403A (es) | Inhibidores de proteasas xi | |
| AR021971A1 (es) | Inhibidores de proteasas | |
| ECSP993293A (es) | Inhibidores de proteasas viii | |
| ECSP982493A (es) | Inhibidores de proteasas iii | |
| ECSP982486A (es) | Inhibidores de proteasas ii | |
| ECSP982481A (es) | Inhibidores de proteasas | |
| PA8541201A1 (es) | Glicina, n-[n-l-gamma-glutamil-3-(nitrosotio)-l-valil] y sus aplicaciones | |
| AR004703A1 (es) | Hidrazidil, bis-hidrazil y bis-aminometil-carbonil, inhibidores de proteasas, una composicin farmaceutica, metodo para inhibir proteasas, y uso en la preparacion de medicamentos. |